Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Proc Natl Acad Sci U S A ; 121(23): e2318843121, 2024 Jun 04.
Artículo en Inglés | MEDLINE | ID: mdl-38805277

RESUMEN

The development and performance of two mass spectrometry (MS) workflows for the intraoperative diagnosis of isocitrate dehydrogenase (IDH) mutations in glioma is implemented by independent teams at Mayo Clinic, Jacksonville, and Huashan Hospital, Shanghai. The infiltrative nature of gliomas makes rapid diagnosis necessary to guide the extent of surgical resection of central nervous system (CNS) tumors. The combination of tissue biopsy and MS analysis used here satisfies this requirement. The key feature of both described methods is the use of tandem MS to measure the oncometabolite 2-hydroxyglutarate (2HG) relative to endogenous glutamate (Glu) to characterize the presence of mutant tumor. The experiments i) provide IDH mutation status for individual patients and ii) demonstrate a strong correlation of 2HG signals with tumor infiltration. The measured ratio of 2HG to Glu correlates with IDH-mutant (IDH-mut) glioma (P < 0.0001) in the tumor core data of both teams. Despite using different ionization methods and different mass spectrometers, comparable performance in determining IDH mutations from core tumor biopsies was achieved with sensitivities, specificities, and accuracies all at 100%. None of the 31 patients at Mayo Clinic or the 74 patients at Huashan Hospital were misclassified when analyzing tumor core biopsies. Robustness of the methodology was evaluated by postoperative re-examination of samples. Both teams noted the presence of high concentrations of 2HG at surgical margins, supporting future use of intraoperative MS to monitor for clean surgical margins. The power of MS diagnostics is shown in resolving contradictory clinical features, e.g., in distinguishing gliosis from IDH-mut glioma.


Asunto(s)
Neoplasias Encefálicas , Glioma , Isocitrato Deshidrogenasa , Mutación , Glioma/genética , Glioma/cirugía , Glioma/patología , Isocitrato Deshidrogenasa/genética , Humanos , Neoplasias Encefálicas/genética , Neoplasias Encefálicas/cirugía , Neoplasias Encefálicas/patología , Espectrometría de Masas en Tándem/métodos , Glutaratos/metabolismo , Espectrometría de Masas/métodos , Ácido Glutámico/metabolismo , Ácido Glutámico/genética
2.
J Colloid Interface Sci ; 585: 750-763, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-33121753

RESUMEN

Evolution of renewable energies in the era of the modernized world has been strongly tied up to the incessant development of high-performance energy storage systems benefiting from both high energy and power densities. In the present work, binder-free positive electrodes are fabricated via a facile electrochemical deposition route in which copper oxide nanorods (CuO NRs) directly grown onto the copper foam (CF) are decorated with bimetallic cobalt-zinc sulfide nanoarrays (Co-Zn-S NAs). The fabricated Co-Zn-S@CuO-CFs represent promising specific capacity of 317.03 C.g-1 at 1.76 A.g-1, along with superior cyclic stability (113% retention after 4500 cycles). Negative electrodes were further prepared through a direct deposition of iron sulfide nanosheets (Fe-S NSs) onto the graphene oxide (GO), showing remarkable the specific capacitance of 543.9 F.g-1 at 0.79 A.g-1. Receiving benefits from remarkable energy and power densities (25.71 Wh.kg-1 and 8.73 kW.kg-1) alongside the reasonable life-stability, the fabricated asymmetric supercapacitor (ASC) devices are on merit for developing high-performance energy storage systems.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA